“…The plasma level of PF4 is proportional to the extent and duration of platelet activation and of PF4 turnover, depending to a large extent on the underlying clinical status of each patient [38]. Increased PF4 levels are observed in inflammatory or infectious disease [39,40], diabetes [41], cardiovascular and renal disease [42-44], atherosclerosis [45] and other conditions affecting vascular health [41,46-48] or in response to traumatic medical procedures [49-51] or cardiopulmonary bypass [52]. Upon release from activated platelets, PF4 rapidly associates with heparan sulfate on endothelial cells and can be brought back into circulation by heparin, for which it has a higher affinity [30,31,53].…”